4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-17-020971
EVP, Chief Financial Officer acquired 5,583 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burke Willaim P EVP, Chief Financial Officer | 2017-06-06 | Grant or award | +5,583 | $41.64 | $232,476 | 15,996 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Burke Willaim P EVP, Chief Financial Officer | 2017-06-06 | Grant or award · Non-qualified Stock Option (Right to Buy) | +22,870 | $41.64 | $952,307 | 22,870 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…